NADH

DB00157ApprovedNutraceuticalSmall molecule

NADH is a nutrient used in some supplement products. NADH is the reduced form of NAD+, and NAD+ is the oxidized form of NADH, a coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage.

Chemical structure of NADH
Mechanism
Curator reviewed
Primary indication
Some evidence suggests that NADH might be useful in treating Parkinson's disease, chronic fatigue syndrome, Alzheimer's disease and cardiovascular disease.Curator reviewed · 5 structured indications
Formula / weight
C21H29N7O14P2 · 665.441 g/mol (avg)
First approval
United States, 2015
Also known as
DPNH · NAD reduced form · Reduced nicotinamide adenine diphosphate · Reduced nicotinamide-adenine dinucleotide
Brand names
  • EnBrace HR
  • EnLyte

Resolves to

Structure
InChIKeyBOPGDPNILDQYTO-NNYOXOHSSA-NSMILESNC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O

What you can answer from here — as of September 12, 2026

144Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
5Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
28Marketed productsAcross 2 countries and 15 labellers
Sign in
320+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with NADH, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account